BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8998598)

  • 1. Chemical synthesis and actions of 11,12-thiirano-hepoxilin A3.
    Demin PM; Reynaud D; Pace-Asciak CR
    J Lipid Mediat Cell Signal; 1996 Jan; 13(1):63-72. PubMed ID: 8998598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepoxilin-evoked intracellular reorganization of calcium in human neutrophils: a confocal microscopy study.
    Mills L; Reynaud D; Pace-Asciak CR
    Exp Cell Res; 1997 Feb; 230(2):337-41. PubMed ID: 9024792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lipid mediator hepoxilin A3 is a natural inducer of neutrophil extracellular traps in human neutrophils.
    Douda DN; Grasemann H; Pace-Asciak C; Palaniyar N
    Mediators Inflamm; 2015; 2015():520871. PubMed ID: 25784781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepoxilin signaling in intact human neutrophils: biphasic elevation of intracellular calcium by unesterified hepoxilin A3.
    Reynaud D; Demin PM; Sutherland M; Nigam S; Pace-Asciak CR
    FEBS Lett; 1999 Mar; 446(2-3):236-8. PubMed ID: 10100848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-mediated action of hepoxilin A3 releases diacylglycerol and arachidonic acid from human neutrophils.
    Nigam S; Nodes S; Cichon G; Corey EJ; Pace-Asciak CR
    Biochem Biophys Res Commun; 1990 Sep; 171(3):944-8. PubMed ID: 2171511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepoxilin A3 is oxidized by human neutrophils into its omega-hydroxy metabolite by an activity independent of LTB4 omega-hydroxylase.
    Reynaud D; Rounova O; Demin PM; Pivnitsky KK; Pace-Asciak CR
    Biochim Biophys Acta; 1997 Oct; 1348(3):287-98. PubMed ID: 9366245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepoxilin binding in human neutrophils.
    Reynaud D; Demin P; Pace-Asciak CR
    Biochem Biophys Res Commun; 1995 Feb; 207(1):191-4. PubMed ID: 7857263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepoxilin A3 inhibits the rise in free intracellular calcium evoked by formyl-methionyl-leucyl-phenylalanine, platelet-activating factor and leukotriene B4.
    Laneuville O; Reynaud D; Grinstein S; Nigam S; Pace-Asciak CR
    Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):393-7. PubMed ID: 8240236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepoxilin A3 inhibits agonist-evoked rise in free intracellular calcium in human neutrophils.
    Pace-Asciak CR; Reynaud D; Laneuville O; Grinstein S; Nigam S
    Adv Exp Med Biol; 1997; 400A():375-80. PubMed ID: 9547579
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepoxilin A3 is metabolized into its omega-hydroxy metabolite by human neutrophils.
    Pace-Asciak CR; Reynaud D; Rounova O; Demin P; Pivnitsky KK
    Adv Exp Med Biol; 1999; 469():535-8. PubMed ID: 10667379
    [No Abstract]   [Full Text] [Related]  

  • 11. Coupling of hepoxilin A3-specific binding with calcium-mobilizing actions in human neutrophils.
    Reynaud D; Demin PM; Pace-Asciak CR
    Agents Actions Suppl; 1995; 45():291-6. PubMed ID: 7717192
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepoxilin A3-specific binding in human neutrophils.
    Reynaud D; Demin P; Pace-Asciak CR
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):537-41. PubMed ID: 8573089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepoxilin A3 formation in the rat pineal gland selectively utilizes (12S)-hydroperoxyeicosatetraenoic acid (HPETE), but not (12R)-HPETE.
    Reynaud D; Demin P; Pace-Asciak CR
    J Biol Chem; 1994 Sep; 269(39):23976-80. PubMed ID: 7929046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A glutathione conjugate of hepoxilin A3: formation and action in the rat central nervous system.
    Pace-Asciak CR; Laneuville O; Su WG; Corey EJ; Gurevich N; Wu P; Carlen PL
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3037-41. PubMed ID: 2326264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries.
    Siangjong L; Goldman DH; Kriska T; Gauthier KM; Smyth EM; Puli N; Kumar G; Falck JR; Campbell WB
    Acta Physiol (Oxf); 2017 Jan; 219(1):188-201. PubMed ID: 26666460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenging the evidence for hepoxilin A
    Brash AR
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L752-L753. PubMed ID: 33021845
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological actions of the free acid of hepoxilin A3 on human neutrophils.
    Sutherland M; Schewe T; Nigam S
    Biochem Pharmacol; 2000 Feb; 59(4):435-40. PubMed ID: 10644052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory
    Patel KK; Webley WC
    Front Immunol; 2018; 9():2357. PubMed ID: 30374355
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioconversion of arachidonic acid into human 14,15-hepoxilin B
    Lee J; Kim TH; Oh DK
    Biotechnol Lett; 2020 Oct; 42(10):2001-2009. PubMed ID: 32488442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epoxide hydratase assay in human platelets using hepoxilin A3 as a lipid substrate.
    Pace-Asciak CR; Klein J; Speilberg SP
    Biochim Biophys Acta; 1986 Feb; 875(2):406-9. PubMed ID: 3942774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.